Rabbit Polyclonal XRN2 antibody. Suitable for IP, WB, IHC-P and reacts with Human, Mouse samples. Cited in 18 publications. Immunogen corresponding to Synthetic Peptide within Human 5'-3' exoribonuclease 2.
View Alternative Names
5'-3' exoribonuclease 2, DHM1-like protein, DHP protein, XRN2
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-XRN2 antibody (AB72181)
IHC image of XRN2 staining in human colon carcinoma formalin fixed paraffin embedded tissue section, performed on a Leica Bond system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab72181, 0.2μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-XRN2 antibody (AB72181)
IHC image of XRN2 staining in mouse renal cell carcinoma formalin fixed paraffin embedded tissue section, performed on a Leica Bond system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab72181, 0.2μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- IP
Unknown
Immunoprecipitation - Anti-XRN2 antibody (AB72181)
Detection of Human XRN2 by Immunoprecipitation in Whole cell lysate from HeLa cells (3 ug per IP reaction), using ab72181 at 3 μg/mg lysate for IP and at 1 μg/ml for subsequent Western blot detection.
All lanes:
Immunoprecipitation - Anti-XRN2 antibody (ab72181)
Predicted band size: 109 kDa
false
- WB
Unknown
Western blot - Anti-XRN2 antibody (AB72181)
All lanes:
Western blot - Anti-XRN2 antibody (ab72181) at 0.4 µg/mL
Lane 1:
TCMK-1 whole cell lysate at 50 µg
Lane 2:
4T1 whole cell lysate at 50 µg
Lane 3:
CT26 whole cell lysate at 50 µg
Predicted band size: 109 kDa
true
Exposure time: 3min
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
5'-3' exoribonuclease 2 regulates the termination of transcription facilitating the completion of the RNA synthesis process. XRN2 functions in coordination with other components within transcription termination complexes such as the exosome. These complexes ensure the removal of excess or faulty RNA which is critical for maintaining cellular homeostasis. XRN2's activity aids in silencing transcriptional noise and preventing the accumulation of defective RNA species.
Pathways
5'-3' RNA decay and termination are where XRN2 finds its primary function. It is a part of the exosome-mediated RNA decay pathway and contributes to effective gene expression pathways. In these pathways XRN2 functions alongside proteins such as Rrp6 and other cofactors ensuring the fidelity of RNA processing is maintained. It interacts with proteins involved in RNA polymerase II-mediated transcriptional processes highlighting its integral role in gene expression regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (18)
Recent publications for all applications. Explore the full list and refine your search
CytoJournal 21:46 PubMed39737134
2024
Applications
Unspecified application
Species
Unspecified reactive species
Developmental cell 57:2731-2744.e5 PubMed36495875
2022
Applications
Unspecified application
Species
Unspecified reactive species
Annals of neurology 93:155-163 PubMed36251395
2022
Applications
Unspecified application
Species
Unspecified reactive species
Free radical biology & medicine 168:25-43 PubMed33785413
2021
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 38:101801 PubMed33232910
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:14253 PubMed32859985
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 9:14063 PubMed31575916
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 76:767-783.e11 PubMed31540874
2019
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 38:e100986 PubMed31267554
2019
Applications
Unspecified application
Species
Unspecified reactive species
eLife 6: PubMed28639940
2017
Applications
WB
Species
Mouse
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com